Risk assessment for nanomaterials involves understanding their physicochemical properties, exposure routes, and biological interactions. Methods such as in vitro and in vivo testing, along with computational modeling, are employed to evaluate the potential hazards. Regulatory frameworks like the REACH Regulation in the European Union provide guidelines for assessing and managing these risks.
